Brain and leptomeningeal metastases from cutaneous melanoma: Survival outcomes based on clinical features
Top Cited Papers
Open Access
- 1 April 2008
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 10 (2) , 199-207
- https://doi.org/10.1215/15228517-2007-058
Abstract
Brain metastases (BM) are among the most devastating and debilitating complications of melanoma. This retrospective study was conducted to gain a betKeywords
This publication has 45 references indexed in Scilit:
- Temozolomide plus thalidomide in patients with brain metastases from melanomaCancer, 2005
- Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastasesInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Temozolomide for the Treatment of Brain Metastases Associated With Metastatic Melanoma: A Phase II StudyJournal of Clinical Oncology, 2004
- Determinants of Outcome in Melanoma Patients With Cerebral MetastasesJournal of Clinical Oncology, 2004
- Survival and Prognostic Factors in Patients with Brain Metastases from Malignant MelanomaOncology Research and Treatment, 2004
- Radiosurgery without whole brain radiotherapy in melanoma brain metastasesEuropean Journal Of Cancer, 1998
- Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanomaJournal of Neurosurgery, 1998
- Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trialsPublished by Elsevier ,1997
- The role of radiation therapy following resection of single brain metastasis from melanomaNeurology, 1990
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958